Actavis Specialty Brands has acquired worldwide rights for Valeant's Metronidazole 1.3% vaginal gel antibiotic development product for approximately $55m. Metronidazole 1.3% vaginal gel antibiotic development product is a topical ...
Tags: Actavis, Metronidazole, Gel Antibiotic